2022
DOI: 10.3233/shti220659
|View full text |Cite
|
Sign up to set email alerts
|

The ERN-LUNG Population Registry: Aims, Software-Implementation and First Results

Abstract: The ERN-LUNG Population Registry is a new European-wide collection of patients with rare lung diseases, allowing patients to register online in the registry. Medical experts can recruit patients in the registry for disease-specific registries and care options. The Population Registry was implemented on the basis of the open source software OSSE and extended by functions for the self-registration of patients. Patients were invited through patient organizations between May and November 2022. 115 patients registe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
(7 reference statements)
0
1
0
Order By: Relevance
“…Supported by recent policies, rare lung disease research experienced unprecedented growth through collaborative efforts in Europe and abroad. ERN-LUNG was established in 2017 and focuses on several rare lung diseases [4,5]. At the same time, the European Respiratory Society (ERS) supports several clinical research collaborations for developing large specific rare lung disease networks, including children's interstitial lung disease, alpha-1 antitrypsin deficiency, and primary ciliary dyskinesia (PCD) [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Supported by recent policies, rare lung disease research experienced unprecedented growth through collaborative efforts in Europe and abroad. ERN-LUNG was established in 2017 and focuses on several rare lung diseases [4,5]. At the same time, the European Respiratory Society (ERS) supports several clinical research collaborations for developing large specific rare lung disease networks, including children's interstitial lung disease, alpha-1 antitrypsin deficiency, and primary ciliary dyskinesia (PCD) [6][7][8].…”
Section: Introductionmentioning
confidence: 99%